Entrada Therapeutics Q1 EPS $(0.42) Beats $(0.76) Estimate, Sales $20.56M Beat $10.17M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.76) by 44.74 percent. This is a 161.76 percent decrease over earnings of $0.68 per share
Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.76) by 44.74 percent. This is a 161.76 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $20.56 million which beat the analyst consensus estimate of $10.17 million by 102.12 percent. This is a 65.23 percent decrease over sales of $59.12 million the same period last year.